Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
This comes as the Appeals board of the European Commission were unable to reach a verdict following the “no opinion” decision of the Standing Committee on Medicinal Products for Human Use and the European Commission. The matter will now be referred the European Commission for a final decision.
ADI releases a position paper on the difficult decisions people with dementia, their families and carers are having to make around hospital admission and triage during COVID-19.
Mario Possenti, CEO of ADI’s member Federazione Alzheimer Italia shares his gratitude to the Italian health workforce for their support of people living with dementia in the wake of the COVID-19 crisis.
Jesús Rodrigo, CEO of ADI’s member Confederación Española de Familiares de Enfermos de Alzheimer (CEAFA) shares his experiences of supporting people with dementia and their carers during the COVID-19 outbreak.
Professor Huali Wang of Alzheimer's Disease Chinese (ADC) explains how China has addressed the specific challenges of people living with dementia during COVID-19.
Datin Jacqueline WM Wong of Demensia Brunei writes about how Malaysia is responding to the needs of Malaysia's most vulnerable and the elderly during the COVID-19 pandemic.
Carmel Geoghegan, Founder of Dementia Ireland, writes about her experience of caring for her mother and the rewards, stigma and life changing experiences it brought.
This year, International Women’s Day focuses on equality, both at the individual and collective level. In part one of this part two series for International Women’s Day, we look at the role of women as carers in dementia care.
ADI's Global Perspective for February 2020 now available.